A QUESTION OF AGM QUESTIONS, page-3

Thanks for your post Mozz. Great idea. Hopefully the power of numbers will result in one or two of our questions being answered.

I think a key question has to be regarding the point that teddywestside88 touched on in the NWR Virtual Conference announcement thread earlier today. There was a reference in one of the NWR Virtual presentation slides to a Ph3 sample size of 1650 people (950 + 700 confirmatory).

Well done on Teddy for seeing the slide that PR was about to speak to before he ran out of time. When I replayed the presentation I think the slide only appeared for about a second. It is a shame PR ran out of time and didn’t get a chance to talk to the slide.

As we all know a total Ph3 sample size n=1150(750 + 400) was announced April 8^th 2020 in the CR presentation. Ithink our question should be to please clarify the sample size for Phase 3given the reference of a larger sample size in the NWR Virtual presentation. Ifthe sample size has materially increased from 1150 please explain the rationaleand is the company still fully funded for an expanded Phase 3 trial?